Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation (NCT04214366)Heidelberg University2019-12-01
Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma (NCT04271800)Chongqing Precision Biotech Co., Ltd2019-12-01
Intratracheal Umbilical Cord-derived Mesenchymal Stem Cell for the Treatment of Bronchopulmonary Dysplasia (BPD) (NCT03645525)Children's Hospital of Fudan University2019-12-01
Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia (NCT04272125)Chongqing Precision Biotech Co., Ltd2019-12-01
BMAC in Severe Hip or Knee Osteoarthritis Awaiting Arthroplasty (NCT03908827)CAPRI Clinic2019-12-01
Second Line Treatment With Nal-IRI and S1 in Pancreatic Cancer (NCT03986294)Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2019-12-01
Autologous Mesenchymal Stem Cells Transplantation in Thoracolumbar Chronic and Complete Spinal Cord Injury Spinal Cord Injury (NCT02574585)Hospital Sao Rafael2019-12-01
LAM561 With RT and TMZ for Adults With Glioblastoma (NCT04250922)Laminar Pharmaceuticals2019-12-01
Adjunctive D-Cycloserine in Major Depressive Disorder (NCT03937596)University of Calgary2019-12-01
Comparison Between Two Drugs (Propofol and Nitroglycerin as a Hypotensive Agents During Endoscopic Sinus Surgery (NCT04220281)Ain Shams University2019-12-01
Cryoablation Combined With Camrelizumab and Apatinib for Multiprimary Lung Cancer (NCT04201990)ShiYue Li2019-12-01
Gallium-68 Labeled LM3 PET/CT in Neuroendocrine Tumors (NCT04318561)Peking Union Medical College Hospital2019-12-01
Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma (NCT03014804)Jonsson Comprehensive Cancer Center2019-12-01
Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma (NCT04272151)Chongqing Precision Biotech Co., Ltd2019-12-01
Safety, Tolerability and PK/PD Evaluation of Intravenous Administration of MRT5201 in Patients With OTC Deficiency (NCT03767270)Translate Bio, Inc.2019-12-01
Clinical Study of Granulocyte Infusion for Advanced Cancer (NCT04124666)Shanghai East Hospital2019-12-01
Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma (NCT04156958)Sichuan University2019-12-01
Hyperbaric Oxygen Treatment in Humans With Gram Positive Cocci Endocarditis (NCT04691440)Ole Hyldegaard2019-12-01
GDF15 Based TPF Induction Chemotherapy for OSCC Patients (NCT02285530)Shanghai Jiao Tong University School of Medicine2019-12-01
Comparative Evaluation of MEBO Ointment and Topical Diltiazem Ointment in the Treatment of Acute Anal Fissure (NCT04153032)American University of Beirut Medical Center2019-12-01
Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma. (NCT04023916)Chinese Academy of Medical Sciences2019-12-01
Alzheimer's Disease: Clinical Investigation and Neuroimage Studies Including 18F-PM-PBB3 and 18F-florbetapir (AV-45) PET Examination (NCT04305210)Chang Gung Memorial Hospital2019-12-01
Autologous Cord Blood and Human Placental Derived Stem Cells in Neonates With Severe Hypoxic-Ischemic Encephalopathy (NCT02434965)New York Medical College2019-12-01
Dual PD-1 and JAK2 Inhibition in Hematological Malignancies (NCT04016116)NYU Langone Health2019-12-01
A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease (NCT03436953)Jazz Pharmaceuticals2019-12-01
Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects with Primary Axillary Hyperhidrosis (NCT04159610)Dr. August Wolff GmbH & Co. KG Arzneimittel2019-12-01
A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD) (NCT02699086)BioLite, Inc.2019-12-01
A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination (NCT04797923)Gangnam Severance Hospital2019-12-01
Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML (NCT04248595)Ge Zheng2019-12-01
Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC (NCT04220528)Fujian Cancer Hospital2019-12-01
Mesotherapy In Lateral Epicondylitis (NCT04201249)Hospital de Santa Maria, Portugal2019-12-01
PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT (NCT04165174)Huazhong University of Science and Technology2019-12-01
Evaluation of the Efficacy of Pirfenidone in Progressive Chronic Hypersensitivity Pneumonitis (NCT04675619)Zagazig University2019-12-01
Study of the Apatinib Combine With POF Versus POF in Gastric Cancer (NCT04121039)Fujian Cancer Hospital2019-12-01
The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor (NCT04179656)Tianjin Medical University Second Hospital2019-12-01
POF Versus FOLFOX Plus IP Paclitaxel in AGC (NCT04155671)Fujian Cancer Hospital2019-12-01
Efficacy of Deep Anaesthesia With Isoflurane as a Fast-response Antidepressant Agent (NCT04171193)University of Sao Paulo2019-12-01
Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC (NCT04153734)Kobe Minimally Invasive Cancer Center2019-12-01
Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy Regimens (NCT04089657)Fujian Cancer Hospital2019-12-01
Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer (NCT03818997)European Organisation for Research and Treatment of Cancer - EORTC2019-12-01
Dexmedetomidine to Levobupivacaine for Transversus Abdominis Plane Block in Elderly Patients Undergoing Inguinal Hernia Repair Surgery (NCT04971759)Assiut University2019-12-01
Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis (NCT03943576)Gwo Xi Stem Cell Applied Technology Co., Ltd.2019-12-01
A Safety and Tolerability Study of GB301 (NCT03865017)VTBIO Co. LTD2019-12-01
Methylene Blue as a Third-line Vasopressor in Septic Shock (NCT04089072)Carilion Clinic2019-12-01
Single-dose Ketamine for the Reduction of Pain and Depression in the Emergency Department (NCT03436121)Maria Pacella2019-12-01
The Role of Brain Radiotherapy in Patients With Asymptomatic Brain Metastasis in the Era of Targeted Therapy for NSCLC (NCT04193007)Second Affiliated Hospital of Nanchang University2019-12-01
SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular Carcinoma (NCT04297202)The First Affiliated Hospital with Nanjing Medical University2019-12-01
Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus (NCT04069949)Sichuan University2019-12-01
A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer (NCT04181372)The First Affiliated Hospital of Guangzhou Medical University2019-12-01
Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer (NCT04199559)Henan Cancer Hospital2019-12-01
NUVOLA TRIAL Open-label Multicentre Study (NCT04261465)Fondazione Policlinico Universitario Agostino Gemelli IRCCS2019-12-01
Safety and Efficacy of γδ T Cell Against Gastric Cancer (NCT02585908)Beijing Doing Biomedical Co., Ltd.2019-12-01
Efficacy and Safety of Pirfenidone Treatment in HPS-ILD (NCT04193592)Jesse Roman2019-12-01
Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis (NCT03167957)Matinas BioPharma Nanotechnologies, Inc.2019-12-01
Analgesic Efficacy of Magnesium Sulphate as an Adjuvant to Levobupivacaine in Erector Spinae Block for Acute Pain Management in Modified Radical Mastectomy (NCT04732390)South Egypt Cancer Institute2019-12-01
Take Off Pounds After Stroke Trial (TOPS) (NCT03815214)Beth Israel Deaconess Medical Center2019-12-01
Effect of Daily Use Proton Pump Inhibitors for One Month on Kidney Function (NCT03910647)Assiut University2019-12-01
Anti-CD19 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphomas (NCT04196205)The First Affiliated Hospital of Nanchang University2019-12-01
Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects (NCT04108104)Kinnov Therapeutics2019-11-30
OMega-3 Fatty Acid for the Immune Modulation of Colorectal Cancer (NCT03661047)Massachusetts General Hospital2019-11-30
Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) (NCT04040361)Masahiro Tsuboi2019-11-30
Role of Ascorbic Acid Infusion in Critically Ill Patients With Transfusion Related Acute Lung Injury (NCT04153487)Damanhour University2019-11-30
Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML (NCT03825367)Therapeutic Advances in Childhood Leukemia Consortium2019-11-29
A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL) (NCT04306887)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2019-11-29
Evaluation of Cabozantinib in Metastatic Renal Cell Carcinoma (mRCC) With Brain Metastases (NCT03967522)Centre Leon Berard2019-11-29
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery (NCT03899987)Roswell Park Cancer Institute2019-11-29
Safety and Efficacy of Melatonin in Patients With Multiple Progressive Primary Sclerosis (NCT03540485)Fundación Pública Andaluza para la gestión de la Investigación en Sevilla2019-11-29
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome (NCT04141969)Optimal Health Research2019-11-29
Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study (NCT04190745)Zhejiang Cancer Hospital2019-11-29
Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A (NCT04069533)Rocket Pharmaceuticals Inc.2019-11-28
Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy (NCT04085250)Sun Yat-sen University2019-11-28
A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer (NCT04241731)Jiangsu Cancer Institute & Hospital2019-11-28
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation (NCT04165031)Eli Lilly and Company2019-11-28
Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer (NCT03947151)Assistance Publique - Hôpitaux de Paris2019-11-28
Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) (NCT04204057)Rhizen Pharmaceuticals SA2019-11-28
Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC (NCT04157140)Jinglong Chen2019-11-28
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) (NCT04179032)GlaxoSmithKline2019-11-28
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) (NCT04110301)Beijing Mabworks Biotech Co., Ltd.2019-11-28
COPD Treatment by Transplantation of Autologous Bronchial Basal Cells (NCT05594303)Guangzhou Institute of Respiratory Disease2019-11-27
Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer (NCT04162873)University of Utah2019-11-27
Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis (NCT04545307)Universidad Central de Venezuela2019-11-27
Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy (NCT04042623)Aravive, Inc.2019-11-27
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression (NCT04040725)Dana-Farber Cancer Institute2019-11-27
Efficacy, Safety, and PK of Ascending Dosages of Moxidectin Versus Ivermectin Against Strongyloides Stercoralis (NCT04056325)Jennifer Keiser2019-11-27
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation (NCT04060277)City of Hope Medical Center2019-11-27
Treatment of Heart Failure Using Human Umbilical Cord Mesenchymal Stem Cells(hUC-MSC) (NCT04939077)Shanghai East Hospital2019-11-27
ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss (NCT04065269)Institute of Cancer Research, United Kingdom2019-11-27
SBRT as a Vaccination for Metastatic Melanoma (NCT04042506)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2019-11-26
DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02) (NCT04014075)Daiichi Sankyo2019-11-26
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia (NCT04158687)Concert Pharmaceuticals2019-11-26
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation (NCT03680092)Dimitrios Tzachanis, MD PhD2019-11-26
Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania (NCT03728153)Massachusetts General Hospital2019-11-26
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM (NCT07217119)GlaxoSmithKline2019-11-26
First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients (NCT04431219)Xenothera SAS2019-11-26
Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (NCT03818854)Michael A. Matthay2019-11-26
Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer (NCT04324307)Changhai Hospital2019-11-26
Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer (NCT03879577)University of Chicago2019-11-25
A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele (NCT04135495)Eloxx Pharmaceuticals, Inc.2019-11-25
Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma (NCT04091217)Hoffmann-La Roche2019-11-25
Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors (NCT04084366)OBI Pharma, Inc2019-11-25
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.